Edward A. Lew MD

Adjunct Assistant Professor, Gastroenterology

72 E. Concord Street
EL
Sections

Gastroenterology

Biography

Dr. Lew, MD is a practicing Gastroenterologist in Jamaica Plain, MA. Dr. Lew graduated from New York University School of Medicine in 1992 and has been in practice for 26 years. He completed a residency at UCLA Medical Center. Dr. Lew also specializes in Internal Medicine.

Education

MD, New York University School of Medicine, 1992

MPH, Yale University School of Medicine, 2000

BS, Columbia University, 1988

Publications

Published on 10/1/2004

Fang M, Lew E, Klein M, Sebo T, Su Y, Goyal R. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues. Am J Gastroenterol. 2004 Oct; 99(10):1887-94. PMID: 15447746.

Published on 3/1/2004

Lew EA. Clarithromycin, lansoprazole, and metronidazole eradicated Helicobacter pylori infection in chronic renal insufficiency. ACP J Club. 2004 Mar-Apr; 140(2):40. PMID: 15122860.

Published on 4/17/2003

Lew EA, Stoffel EM. Natalizumab for active Crohn's disease. N Engl J Med. 2003 Apr 17; 348(16):1599; author reply 1599. PMID: 12700383.

Published on 12/1/2001

Metz DC, Forsmark C, Lew EA, Starr JA, Soffer EF, Bochenek W, Pisegna JR. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Am J Gastroenterol. 2001 Dec; 96(12):3274-80. PMID: 11774936.

Published on 7/1/2001

Lew EA, Goyal RK. The enigma of short-segment Barrett's esophagus. Indian J Gastroenterol. 2001 Jul-Aug; 20(4):130-1. PMID: 11497168.

Published on 4/1/2000

Lew EA, Pisegna JR, Starr JA, Soffer EF, Forsmark C, Modlin IM, Walsh JH, Beg M, Bochenek W, Metz DC. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology. 2000 Apr; 118(4):696-704. PMID: 10734021.

Published on 10/1/1999

Lew EA. Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy. Aliment Pharmacol Ther. 1999 Oct; 13 Suppl 5:11-6. PMID: 10555604.

Published on 6/1/1999

Lew EA, Lewin KJ, Zarchy T, Pisegna JR. Adenocarcinoma of the colon with neuroendocrine features and secretory diarrhea. Am J Gastroenterol. 1999 Jun; 94(6):1692-4. PMID: 10364049.

Published on 7/1/1998

Lew EA, Barbuti RC, Kovacs TO, Sytnic B, Humphries TJ, Walsh JH. An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810). Aliment Pharmacol Ther. 1998 Jul; 12(7):667-72. PMID: 9701531.

Published on 6/1/1997

Dieterich DT, Poles MA, Lew EA, Martin-Munley S, Johnson J, Nix D, Faust MJ. Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS. Antimicrob Agents Chemother. 1997 Jun; 41(6):1226-30. PMID: 9174175.

View full list of 18 publications.